Chou et al reported that for patients with severe sepsis due to secondary peritonitis, albumin administration may reduce 28-day mortality, however this mortality benefit was limited to patients whose baseline serum albumin is 20 g/L or lower [45]. The gene discussed is ALB; the disease is Sepsis.